MX2020007403A - Compuestos de tetrahidroisoquinolina. - Google Patents

Compuestos de tetrahidroisoquinolina.

Info

Publication number
MX2020007403A
MX2020007403A MX2020007403A MX2020007403A MX2020007403A MX 2020007403 A MX2020007403 A MX 2020007403A MX 2020007403 A MX2020007403 A MX 2020007403A MX 2020007403 A MX2020007403 A MX 2020007403A MX 2020007403 A MX2020007403 A MX 2020007403A
Authority
MX
Mexico
Prior art keywords
tetrahydroisoquinoline compounds
compounds
tetrahydroisoquinoline
compositions
present
Prior art date
Application number
MX2020007403A
Other languages
English (en)
Inventor
García Miguel Vega
Muelas Pedro Campos
Romero Esther Carrasco
Pérez Asunción Burguete
Gutiérrez Patricia Gómez
González Juan Jesús Pérez
Peypoch Ángel Messeguer
Sánchez Balbino José Alarcón
Rojo Irene Azahara Arellano
Original Assignee
Allinky Biopharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allinky Biopharma filed Critical Allinky Biopharma
Publication of MX2020007403A publication Critical patent/MX2020007403A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se relaciona con una clase novedosa de compuestos de tetrahidroisoquinolina de la fórmula I y con las composiciones que comprenden los mismos. Los compuestos y las composiciones de la presente invención se pueden utilizar como medicamentos en el tratamiento del cáncer.
MX2020007403A 2018-01-10 2019-01-10 Compuestos de tetrahidroisoquinolina. MX2020007403A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382010 2018-01-10
PCT/EP2019/050518 WO2019137985A1 (en) 2018-01-10 2019-01-10 Tetrahydroisoquinoline compounds

Publications (1)

Publication Number Publication Date
MX2020007403A true MX2020007403A (es) 2020-11-11

Family

ID=62104212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007403A MX2020007403A (es) 2018-01-10 2019-01-10 Compuestos de tetrahidroisoquinolina.

Country Status (10)

Country Link
US (1) US11466012B2 (es)
EP (1) EP3737677B1 (es)
JP (1) JP2021510699A (es)
CN (1) CN112262137A (es)
CA (1) CA3087888A1 (es)
DK (1) DK3737677T3 (es)
ES (1) ES2905568T3 (es)
MX (1) MX2020007403A (es)
RU (1) RU2020126188A (es)
WO (1) WO2019137985A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3880668B1 (en) 2018-11-14 2023-12-20 Allinky Biopharma Pyridin-sulfonamide compounds for the treatment of conditions related to interleukin 1 beta
EP3763711A1 (en) * 2019-07-09 2021-01-13 Allinky Biopharma Tetrahydroisoquinoline compounds
IL299131A (en) 2020-06-18 2023-02-01 Revolution Medicines Inc Methods for delaying, preventing and treating acquired resistance to RAS inhibitors
US20250195521A1 (en) 2020-09-03 2025-06-19 Revolution Medicines, Inc. Use of sos1 inhibitors to treat malignancies with shp2 mutations
WO2023169481A1 (zh) * 2022-03-09 2023-09-14 思路迪生物医药(上海)有限公司 一类作为泛-kras抑制剂的四氢异喹啉类衍生物及其制备方法和应用
CN114874201B (zh) * 2022-04-08 2023-01-20 思路迪生物医药(上海)有限公司 一类泛-kras抑制剂及其制备和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369226B1 (en) 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
IL157093A0 (en) * 2001-03-27 2004-02-08 Actelion Pharmaceuticals Ltd 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
SE0303542D0 (sv) * 2003-12-22 2003-12-22 Astrazeneca Ab 1,2,3,4-Tetrahydroisoquinoline derivaties, preparations thereof and uses thereof
NZ552397A (en) * 2004-07-15 2011-04-29 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
SG174095A1 (en) 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
SG2012079653A (en) 2007-10-25 2014-05-29 Exelixis Inc Tropane compounds
US8343961B2 (en) 2009-03-31 2013-01-01 Arqule, Inc. Substituted heterocyclic compounds
MX2012001156A (es) 2009-07-28 2012-05-08 Anacor Pharmaceuticals Inc Moleculas que contienen boro trisustituidas.
AU2014362231B2 (en) 2013-12-11 2019-04-04 Biogen Ma Inc. Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
EP3549582B1 (en) 2014-08-29 2024-10-30 The Board of Regents of The University of Texas System Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
CN106117182B (zh) * 2016-06-20 2019-08-30 中国药科大学 喹唑啉-n-苯乙基四氢异喹啉类化合物及其制备方法和应用
EP3880668B1 (en) 2018-11-14 2023-12-20 Allinky Biopharma Pyridin-sulfonamide compounds for the treatment of conditions related to interleukin 1 beta

Also Published As

Publication number Publication date
US11466012B2 (en) 2022-10-11
DK3737677T3 (da) 2022-01-10
ES2905568T3 (es) 2022-04-11
EP3737677B1 (en) 2021-11-03
WO2019137985A1 (en) 2019-07-18
CN112262137A (zh) 2021-01-22
EP3737677A1 (en) 2020-11-18
CA3087888A1 (en) 2019-07-18
US20200369671A1 (en) 2020-11-26
RU2020126188A (ru) 2022-02-10
JP2021510699A (ja) 2021-04-30

Similar Documents

Publication Publication Date Title
MX2020007403A (es) Compuestos de tetrahidroisoquinolina.
ZA202405294B (en) Heterocyclic compounds as immunomodulators
PH12020550857A1 (en) Polycyclic compounds as allosteric shp2 inhibitors
MY209609A (en) Immunomodulators, compositions and methods thereof
MX2022005290A (es) Compuestos heterociclicos como inmunomoduladores.
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
MD20170016A2 (ro) Compuşi aminopirimidinici ca inhibitori JAK
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
MY199220A (en) Heterocyclic compounds as immunomodulators
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
GEP201706725B (en) Compounds and compositions as inhibitors of mek
MX366123B (es) Sulfamoil-arilamidas y el uso de las mismas como medicamentos para el tratamiento de la hepatitis b.
NZ748946A (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2018005041A (es) Compuestos para tratar la esclerosis lateral amiotrofica.
PH12015502365A1 (en) Bace1 inhibitors
MY202884A (en) Compounds useful in hiv therapy
PH12020550252A1 (en) Novel phenylpyridine derivative and pharmaceutical composition comprising the same
MX388592B (es) Compuestos y metodos terapeuticos.
GEAP201814266A (en) Pyrazines modulators of gpr6
MX2015017446A (es) Nuevos derivados de amidinourea macrociclica, metodos de preparacion y usos de los mismos como inhibidores de quitinasa.
PH12018501585B1 (en) Novel pyrrolidine derivatives
MX2016001357A (es) Compuestos de ciclobutilo 1,2-disustituidos.